Dun & Bradstreet saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, rising from 69 to 73.
IBD's proprietary rating measures share price movement with a 1 (worst) to 99 (best) score. The score shows how a stock's price movement over the trailing 52 weeks stacks up against all the other stocks in our database.
Decades of market research shows that the top-performing stocks typically have an RS Rating north of 80 as they launch their biggest price moves. See if Dun & Bradstreet can continue to rebound and hit that benchmark.
How To Invest In Stocks In Both Bull And Bear Markets
Dun & Bradstreet is working on a consolidation with a 12.95 buy point. See if the stock can clear the breakout price in heavy volume.
The company reported 0% EPS growth in the latest quarterly report. Revenue rose 4%. Keep an eye out for the company's next round of numbers on or around Feb. 13.
The company earns the No. 10 rank among its peers in the Commercial Services-Market Research industry group. Moody's, Gartner Inc and S&P Global are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
